Where does Cedars Sinai Medical Center rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cedars Sinai Medical Center ranks #1,369 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cedars Sinai Medical Center hold?

Cedars Sinai Medical Center holds 306 US utility patents granted between 2015 and 2025, spanning 48 technology areas.

What is Cedars Sinai Medical Center's Innovation Score?

Cedars Sinai Medical Center has an Innovation Score of 61.2 out of 100 (top 3% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cedars Sinai Medical Center focus on?

Cedars Sinai Medical Center's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 158 patents, ranking #109 of 7,163 assignees active in that subclass. Grants appear in 48 CPC subclasses total.

Is Cedars Sinai Medical Center's patent grant rate increasing or decreasing?

Cedars Sinai Medical Center's recent grant velocity is +69% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Cedars Sinai Medical Center's patents?

Cedars Sinai Medical Center's patents average 17.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cedars Sinai Medical Center patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cedars Sinai Medical Center

USPTO PatentsView assignee record - 306 granted patents across 48 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cedars ranks #1,369 of 49,997 tracked US assignees by granted-patent volume, with 306 patents across 48 technology areas.

#1,369
of 49,997 US assignees by volume: Top 3%
by Innovation Score (61.2/100): 17.0
avg claims per patent: +69%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1369 · US Corporation #1,369 · 306 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 306 grants
TOP-DECILE #1,369/49,997
PHOTO-FINISH Alfa Laval Corporate…
CPC-WIDE A61K · 48 areas
INNOV-STRONG 61.2/100
CLAIMS-RICH 17.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +69% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Alfa Laval Corporate AB (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cedars’s 61.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 19.8 pts (32%) Velocity 6.7 pts (11%) Breadth 24.5 pts (40%) Claim depth 10.2 pts (17%)

Qualcomm Incorporated · highest

85
Ceremorphic · near

61
Morgan Stanley… · near

61
Cedars Sinai… · this assignee

61
Fanuc · near

61
The George Washingto… · near

61
3D Lighting… · lowest

7

What this shows Cedars's Innovation Score is 61.2/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cedars?

Each dot is one of Cedars’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cedars’s own 17.0 claims/patent is at or below the 17.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Cedars vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cedars's grants concentrate

Cedars Sinai Medical Center is a focused PatentsView assignee: 48 CPC subclasses with 51.6% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (40 grants) versus a trough of 15 in 2015. By volume, Cedars sits between The Chinese University of Hong Kong and STMicroelectronics (Research & Development) Limited.

Cedars's three-year grant acceleration

From 2019–2021 to 2022–2024, Cedars Sinai Medical Center moved from 100 to 101 grants (1.01x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,157. See the growth leaderboard.

The Chinese Unive…

307
Verizon Media

307
Alfa Laval Corpor…

306
Bissell

306
Coulter Ventures

306
DRÄGerwerk & Kgaa

306
FMR

306
Stmicroelectronic…

306
Cedars Sinai Medi… ◀

306

What this shows Cedars holds 306 patents at rank #1,369, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cedars

By rank, the assignees closest to #1,369 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Cedars's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cedars, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Cedars ranks #109 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (61 here).

Morgan Stanley Services Group Inc. 61 Fanuc Corporation 61 The George Washington University 61 Ceremorphic, Inc. 61

Similar claim depth

Nearest assignees by average claims per patent (17.0 here).

EGALAX_EMPIA Technology Inc. 17.0 avg Rolls-Royce North American Technologies Inc. 17.0 avg Lutron Technology Company LLC 17.0 avg Wangs Alliance Corporation 17.0 avg

Cedars's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

61 Top 3% higher than 97% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Cedars Sinai Medical Center patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	15	4.9%
2016	18	5.9%
2017	24	7.8%
2018	16	5.2%
2019	29	9.5%
2020	40	13.1%
2021	31	10.1%
2022	37	12.1%
2023	32	10.5%
2024	32	10.5%
2025partial year	32	10.5%

Which technologies does Cedars Sinai Medical Center patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 158

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 139

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 83

A61B - DIAGNOSIS; SURGERY; Identification 72

C07K - Peptides 71

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 63

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 58

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 24

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 24

Y02A - Technologies FOR Adaptation TO Climate Change 17

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 16

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 14

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 13

G06T - Image Data Processing OR Generation, IN General 12

C07D - Heterocyclic Compounds 11

Top 15 of 48 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cedars Sinai Medical Center's patent record in context - here's where to go next.

Cedars Sinai Medical Center's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 51.6% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #1,369 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cedars Sinai Medical Center against The Chinese University of Hong Kong, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 61.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.